 | • レポートコード：GIR-23F3829 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Human Rabies Vaccines Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界のヒト狂犬病ワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 ヒト狂犬病ワクチン市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・Vero細胞狂犬病ワクチン、BHK、ニワトリ胚細胞狂犬病ワクチン、その他 アプリケーション別セグメントは次のように区分されます。 ・曝露前予防、曝露後予防 世界のヒト狂犬病ワクチン市場の主要なマーケットプレーヤーは以下のとおりです。 ・Sanofi Pasteur，Inc.、Novartis Vaccines and Diagnostics Ltd.、Cadila Pharmaceuticals Ltd.、GlaxoSmithKline Biologicals、Merck＆Co Inc.、Wyeth pharmaceuticals、Berna Biotech Ltd.、Medimmune LLC 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - ヒト狂犬病ワクチンの概要 - タイプ別分析（2017年vs2021年vs2028年）：Vero細胞狂犬病ワクチン、BHK、ニワトリ胚細胞狂犬病ワクチン、その他 - アプリケーション別分析（2017年vs2021年vs2028年）：曝露前予防、曝露後予防 - 世界のヒト狂犬病ワクチン市場規模・予測 - 世界のヒト狂犬病ワクチン生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Sanofi Pasteur，Inc.、Novartis Vaccines and Diagnostics Ltd.、Cadila Pharmaceuticals Ltd.、GlaxoSmithKline Biologicals、Merck＆Co Inc.、Wyeth pharmaceuticals、Berna Biotech Ltd.、Medimmune LLC ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：Vero細胞狂犬病ワクチン、BHK、ニワトリ胚細胞狂犬病ワクチン、その他 ・アプリケーション別分析2017年-2028年：曝露前予防、曝露後予防 ・ヒト狂犬病ワクチンの北米市場分析 - ヒト狂犬病ワクチンの北米市場：タイプ別市場規模2017年-2028年 - ヒト狂犬病ワクチンの北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・ヒト狂犬病ワクチンのヨーロッパ市場分析 - ：ヒト狂犬病ワクチンのヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：ヒト狂犬病ワクチンのヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・ヒト狂犬病ワクチンのアジア太平洋市場分析 - ヒト狂犬病ワクチンのアジア太平洋市場：タイプ別市場規模2017年-2028年 - ヒト狂犬病ワクチンのアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・ヒト狂犬病ワクチンの南米市場分析 - ヒト狂犬病ワクチンの南米市場：タイプ別市場規模2017年-2028年 - ヒト狂犬病ワクチンの南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・ヒト狂犬病ワクチンの中東・アフリカ市場分析 - ヒト狂犬病ワクチンの中東・アフリカ市場：タイプ別市場規模2017年-2028年 - ヒト狂犬病ワクチンの中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Human Rabies Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Human Rabies Vaccines market size is estimated to be worth US$ 1086.6 million in 2021 and is forecast to a readjusted size of USD 1432.6 million by 2028 with a CAGR of 4.0% during review period. Pre-Exposure Prophylaxis accounting for % of the Human Rabies Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Vero Cell Rabies Vaccine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Human Rabies Vaccines include Sanofi Pasteur，Inc., Novartis Vaccines and Diagnostics Ltd., Cadila Pharmaceuticals Ltd., GlaxoSmithKline Biologicals, and Merck＆Co Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Human Rabies Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Others
Market segment by Application can be divided into
Pre-Exposure Prophylaxis
Post-Exposure Prophylaxis
The key market players for global Human Rabies Vaccines market are listed below:
Sanofi Pasteur，Inc.
Novartis Vaccines and Diagnostics Ltd.
Cadila Pharmaceuticals Ltd.
GlaxoSmithKline Biologicals
Merck＆Co Inc.
Wyeth pharmaceuticals
Berna Biotech Ltd.
Medimmune LLC
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Rabies Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Rabies Vaccines, with price, sales, revenue and global market share of Human Rabies Vaccines from 2019 to 2022.
Chapter 3, the Human Rabies Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Rabies Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Human Rabies Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Rabies Vaccines.
Chapter 13, 14, and 15, to describe Human Rabies Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Human Rabies Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Rabies Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Vero Cell Rabies Vaccine
1.2.3 BHK
1.2.4 Chick Embryo Cell Rabies Vaccine
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Rabies Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Pre-Exposure Prophylaxis
1.3.3 Post-Exposure Prophylaxis
1.4 Global Human Rabies Vaccines Market Size & Forecast
1.4.1 Global Human Rabies Vaccines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Human Rabies Vaccines Sales in Volume (2017-2028)
1.4.3 Global Human Rabies Vaccines Price (2017-2028)
1.5 Global Human Rabies Vaccines Production Capacity Analysis
1.5.1 Global Human Rabies Vaccines Total Production Capacity (2017-2028)
1.5.2 Global Human Rabies Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Rabies Vaccines Market Drivers
1.6.2 Human Rabies Vaccines Market Restraints
1.6.3 Human Rabies Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi Pasteur，Inc.
2.1.1 Sanofi Pasteur，Inc. Details
2.1.2 Sanofi Pasteur，Inc. Major Business
2.1.3 Sanofi Pasteur，Inc. Human Rabies Vaccines Product and Services
2.1.4 Sanofi Pasteur，Inc. Human Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Novartis Vaccines and Diagnostics Ltd.
2.2.1 Novartis Vaccines and Diagnostics Ltd. Details
2.2.2 Novartis Vaccines and Diagnostics Ltd. Major Business
2.2.3 Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Product and Services
2.2.4 Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Cadila Pharmaceuticals Ltd.
2.3.1 Cadila Pharmaceuticals Ltd. Details
2.3.2 Cadila Pharmaceuticals Ltd. Major Business
2.3.3 Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Product and Services
2.3.4 Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 GlaxoSmithKline Biologicals
2.4.1 GlaxoSmithKline Biologicals Details
2.4.2 GlaxoSmithKline Biologicals Major Business
2.4.3 GlaxoSmithKline Biologicals Human Rabies Vaccines Product and Services
2.4.4 GlaxoSmithKline Biologicals Human Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Merck＆Co Inc.
2.5.1 Merck＆Co Inc. Details
2.5.2 Merck＆Co Inc. Major Business
2.5.3 Merck＆Co Inc. Human Rabies Vaccines Product and Services
2.5.4 Merck＆Co Inc. Human Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Wyeth pharmaceuticals
2.6.1 Wyeth pharmaceuticals Details
2.6.2 Wyeth pharmaceuticals Major Business
2.6.3 Wyeth pharmaceuticals Human Rabies Vaccines Product and Services
2.6.4 Wyeth pharmaceuticals Human Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Berna Biotech Ltd.
2.7.1 Berna Biotech Ltd. Details
2.7.2 Berna Biotech Ltd. Major Business
2.7.3 Berna Biotech Ltd. Human Rabies Vaccines Product and Services
2.7.4 Berna Biotech Ltd. Human Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Medimmune LLC
2.8.1 Medimmune LLC Details
2.8.2 Medimmune LLC Major Business
2.8.3 Medimmune LLC Human Rabies Vaccines Product and Services
2.8.4 Medimmune LLC Human Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Human Rabies Vaccines Breakdown Data by Manufacturer
3.1 Global Human Rabies Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Human Rabies Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Human Rabies Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Human Rabies Vaccines Manufacturer Market Share in 2021
3.4.2 Top 6 Human Rabies Vaccines Manufacturer Market Share in 2021
3.5 Global Human Rabies Vaccines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Human Rabies Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Rabies Vaccines Market Size by Region
4.1.1 Global Human Rabies Vaccines Sales in Volume by Region (2017-2028)
4.1.2 Global Human Rabies Vaccines Revenue by Region (2017-2028)
4.2 North America Human Rabies Vaccines Revenue (2017-2028)
4.3 Europe Human Rabies Vaccines Revenue (2017-2028)
4.4 Asia-Pacific Human Rabies Vaccines Revenue (2017-2028)
4.5 South America Human Rabies Vaccines Revenue (2017-2028)
4.6 Middle East and Africa Human Rabies Vaccines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Human Rabies Vaccines Sales in Volume by Type (2017-2028)
5.2 Global Human Rabies Vaccines Revenue by Type (2017-2028)
5.3 Global Human Rabies Vaccines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Human Rabies Vaccines Sales in Volume by Application (2017-2028)
6.2 Global Human Rabies Vaccines Revenue by Application (2017-2028)
6.3 Global Human Rabies Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Human Rabies Vaccines Sales by Type (2017-2028)
7.2 North America Human Rabies Vaccines Sales by Application (2017-2028)
7.3 North America Human Rabies Vaccines Market Size by Country
7.3.1 North America Human Rabies Vaccines Sales in Volume by Country (2017-2028)
7.3.2 North America Human Rabies Vaccines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Rabies Vaccines Sales by Type (2017-2028)
8.2 Europe Human Rabies Vaccines Sales by Application (2017-2028)
8.3 Europe Human Rabies Vaccines Market Size by Country
8.3.1 Europe Human Rabies Vaccines Sales in Volume by Country (2017-2028)
8.3.2 Europe Human Rabies Vaccines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Human Rabies Vaccines Sales by Type (2017-2028)
9.2 Asia-Pacific Human Rabies Vaccines Sales by Application (2017-2028)
9.3 Asia-Pacific Human Rabies Vaccines Market Size by Region
9.3.1 Asia-Pacific Human Rabies Vaccines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Human Rabies Vaccines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Human Rabies Vaccines Sales by Type (2017-2028)
10.2 South America Human Rabies Vaccines Sales by Application (2017-2028)
10.3 South America Human Rabies Vaccines Market Size by Country
10.3.1 South America Human Rabies Vaccines Sales in Volume by Country (2017-2028)
10.3.2 South America Human Rabies Vaccines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Rabies Vaccines Sales by Type (2017-2028)
11.2 Middle East & Africa Human Rabies Vaccines Sales by Application (2017-2028)
11.3 Middle East & Africa Human Rabies Vaccines Market Size by Country
11.3.1 Middle East & Africa Human Rabies Vaccines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Human Rabies Vaccines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Human Rabies Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of Human Rabies Vaccines
12.3 Human Rabies Vaccines Production Process
12.4 Human Rabies Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Human Rabies Vaccines Typical Distributors
13.3 Human Rabies Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Human Rabies Vaccines Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Human Rabies Vaccines Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Sanofi Pasteur，Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Pasteur，Inc. Major Business
Table 5. Sanofi Pasteur，Inc. Human Rabies Vaccines Product and Services
Table 6. Sanofi Pasteur，Inc. Human Rabies Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Novartis Vaccines and Diagnostics Ltd. Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Vaccines and Diagnostics Ltd. Major Business
Table 9. Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Product and Services
Table 10. Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Cadila Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table 12. Cadila Pharmaceuticals Ltd. Major Business
Table 13. Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Product and Services
Table 14. Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. GlaxoSmithKline Biologicals Basic Information, Manufacturing Base and Competitors
Table 16. GlaxoSmithKline Biologicals Major Business
Table 17. GlaxoSmithKline Biologicals Human Rabies Vaccines Product and Services
Table 18. GlaxoSmithKline Biologicals Human Rabies Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Merck＆Co Inc. Basic Information, Manufacturing Base and Competitors
Table 20. Merck＆Co Inc. Major Business
Table 21. Merck＆Co Inc. Human Rabies Vaccines Product and Services
Table 22. Merck＆Co Inc. Human Rabies Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Wyeth pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Wyeth pharmaceuticals Major Business
Table 25. Wyeth pharmaceuticals Human Rabies Vaccines Product and Services
Table 26. Wyeth pharmaceuticals Human Rabies Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Berna Biotech Ltd. Basic Information, Manufacturing Base and Competitors
Table 28. Berna Biotech Ltd. Major Business
Table 29. Berna Biotech Ltd. Human Rabies Vaccines Product and Services
Table 30. Berna Biotech Ltd. Human Rabies Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Medimmune LLC Basic Information, Manufacturing Base and Competitors
Table 32. Medimmune LLC Major Business
Table 33. Medimmune LLC Human Rabies Vaccines Product and Services
Table 34. Medimmune LLC Human Rabies Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Human Rabies Vaccines Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 36. Global Human Rabies Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Human Rabies Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Human Rabies Vaccines Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Human Rabies Vaccines Production Site of Key Manufacturer
Table 40. Human Rabies Vaccines New Entrant and Capacity Expansion Plans
Table 41. Human Rabies Vaccines Mergers & Acquisitions in the Past Five Years
Table 42. Global Human Rabies Vaccines Sales by Region (2017-2022) & (K Units)
Table 43. Global Human Rabies Vaccines Sales by Region (2023-2028) & (K Units)
Table 44. Global Human Rabies Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Human Rabies Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Human Rabies Vaccines Sales by Type (2017-2022) & (K Units)
Table 47. Global Human Rabies Vaccines Sales by Type (2023-2028) & (K Units)
Table 48. Global Human Rabies Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Human Rabies Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Human Rabies Vaccines Price by Type (2017-2022) & (USD/Unit)
Table 51. Global Human Rabies Vaccines Price by Type (2023-2028) & (USD/Unit)
Table 52. Global Human Rabies Vaccines Sales by Application (2017-2022) & (K Units)
Table 53. Global Human Rabies Vaccines Sales by Application (2023-2028) & (K Units)
Table 54. Global Human Rabies Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Human Rabies Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Human Rabies Vaccines Price by Application (2017-2022) & (USD/Unit)
Table 57. Global Human Rabies Vaccines Price by Application (2023-2028) & (USD/Unit)
Table 58. North America Human Rabies Vaccines Sales by Country (2017-2022) & (K Units)
Table 59. North America Human Rabies Vaccines Sales by Country (2023-2028) & (K Units)
Table 60. North America Human Rabies Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Human Rabies Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Human Rabies Vaccines Sales by Type (2017-2022) & (K Units)
Table 63. North America Human Rabies Vaccines Sales by Type (2023-2028) & (K Units)
Table 64. North America Human Rabies Vaccines Sales by Application (2017-2022) & (K Units)
Table 65. North America Human Rabies Vaccines Sales by Application (2023-2028) & (K Units)
Table 66. Europe Human Rabies Vaccines Sales by Country (2017-2022) & (K Units)
Table 67. Europe Human Rabies Vaccines Sales by Country (2023-2028) & (K Units)
Table 68. Europe Human Rabies Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Human Rabies Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Human Rabies Vaccines Sales by Type (2017-2022) & (K Units)
Table 71. Europe Human Rabies Vaccines Sales by Type (2023-2028) & (K Units)
Table 72. Europe Human Rabies Vaccines Sales by Application (2017-2022) & (K Units)
Table 73. Europe Human Rabies Vaccines Sales by Application (2023-2028) & (K Units)
Table 74. Asia-Pacific Human Rabies Vaccines Sales by Region (2017-2022) & (K Units)
Table 75. Asia-Pacific Human Rabies Vaccines Sales by Region (2023-2028) & (K Units)
Table 76. Asia-Pacific Human Rabies Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Human Rabies Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Human Rabies Vaccines Sales by Type (2017-2022) & (K Units)
Table 79. Asia-Pacific Human Rabies Vaccines Sales by Type (2023-2028) & (K Units)
Table 80. Asia-Pacific Human Rabies Vaccines Sales by Application (2017-2022) & (K Units)
Table 81. Asia-Pacific Human Rabies Vaccines Sales by Application (2023-2028) & (K Units)
Table 82. South America Human Rabies Vaccines Sales by Country (2017-2022) & (K Units)
Table 83. South America Human Rabies Vaccines Sales by Country (2023-2028) & (K Units)
Table 84. South America Human Rabies Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Human Rabies Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Human Rabies Vaccines Sales by Type (2017-2022) & (K Units)
Table 87. South America Human Rabies Vaccines Sales by Type (2023-2028) & (K Units)
Table 88. South America Human Rabies Vaccines Sales by Application (2017-2022) & (K Units)
Table 89. South America Human Rabies Vaccines Sales by Application (2023-2028) & (K Units)
Table 90. Middle East & Africa Human Rabies Vaccines Sales by Region (2017-2022) & (K Units)
Table 91. Middle East & Africa Human Rabies Vaccines Sales by Region (2023-2028) & (K Units)
Table 92. Middle East & Africa Human Rabies Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Human Rabies Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Human Rabies Vaccines Sales by Type (2017-2022) & (K Units)
Table 95. Middle East & Africa Human Rabies Vaccines Sales by Type (2023-2028) & (K Units)
Table 96. Middle East & Africa Human Rabies Vaccines Sales by Application (2017-2022) & (K Units)
Table 97. Middle East & Africa Human Rabies Vaccines Sales by Application (2023-2028) & (K Units)
Table 98. Human Rabies Vaccines Raw Material
Table 99. Key Manufacturers of Human Rabies Vaccines Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Human Rabies Vaccines Typical Distributors
Table 103. Human Rabies Vaccines Typical Customers
List of Figures
Figure 1. Human Rabies Vaccines Picture
Figure 2. Global Human Rabies Vaccines Revenue Market Share by Type in 2021
Figure 3. Vero Cell Rabies Vaccine
Figure 4. BHK
Figure 5. Chick Embryo Cell Rabies Vaccine
Figure 6. Others
Figure 7. Global Human Rabies Vaccines Revenue Market Share by Application in 2021
Figure 8. Pre-Exposure Prophylaxis
Figure 9. Post-Exposure Prophylaxis
Figure 10. Global Human Rabies Vaccines Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Human Rabies Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Human Rabies Vaccines Sales (2017-2028) & (K Units)
Figure 13. Global Human Rabies Vaccines Price (2017-2028) & (USD/Unit)
Figure 14. Global Human Rabies Vaccines Production Capacity (2017-2028) & (K Units)
Figure 15. Global Human Rabies Vaccines Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Human Rabies Vaccines Market Drivers
Figure 17. Human Rabies Vaccines Market Restraints
Figure 18. Human Rabies Vaccines Market Trends
Figure 19. Global Human Rabies Vaccines Sales Market Share by Manufacturer in 2021
Figure 20. Global Human Rabies Vaccines Revenue Market Share by Manufacturer in 2021
Figure 21. Human Rabies Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Human Rabies Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Human Rabies Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Human Rabies Vaccines Sales Market Share by Region (2017-2028)
Figure 25. Global Human Rabies Vaccines Revenue Market Share by Region (2017-2028)
Figure 26. North America Human Rabies Vaccines Revenue (2017-2028) & (USD Million)
Figure 27. Europe Human Rabies Vaccines Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Human Rabies Vaccines Revenue (2017-2028) & (USD Million)
Figure 29. South America Human Rabies Vaccines Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Human Rabies Vaccines Revenue (2017-2028) & (USD Million)
Figure 31. Global Human Rabies Vaccines Sales Market Share by Type (2017-2028)
Figure 32. Global Human Rabies Vaccines Revenue Market Share by Type (2017-2028)
Figure 33. Global Human Rabies Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 34. Global Human Rabies Vaccines Sales Market Share by Application (2017-2028)
Figure 35. Global Human Rabies Vaccines Revenue Market Share by Application (2017-2028)
Figure 36. Global Human Rabies Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 37. North America Human Rabies Vaccines Sales Market Share by Type (2017-2028)
Figure 38. North America Human Rabies Vaccines Sales Market Share by Application (2017-2028)
Figure 39. North America Human Rabies Vaccines Sales Market Share by Country (2017-2028)
Figure 40. North America Human Rabies Vaccines Revenue Market Share by Country (2017-2028)
Figure 41. United States Human Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Human Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Human Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Human Rabies Vaccines Sales Market Share by Type (2017-2028)
Figure 45. Europe Human Rabies Vaccines Sales Market Share by Application (2017-2028)
Figure 46. Europe Human Rabies Vaccines Sales Market Share by Country (2017-2028)
Figure 47. Europe Human Rabies Vaccines Revenue Market Share by Country (2017-2028)
Figure 48. Germany Human Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Human Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Human Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Human Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Human Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Human Rabies Vaccines Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Human Rabies Vaccines Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Human Rabies Vaccines Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Human Rabies Vaccines Revenue Market Share by Region (2017-2028)
Figure 57. China Human Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Human Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Human Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Human Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Human Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Human Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Human Rabies Vaccines Sales Market Share by Type (2017-2028)
Figure 64. South America Human Rabies Vaccines Sales Market Share by Application (2017-2028)
Figure 65. South America Human Rabies Vaccines Sales Market Share by Country (2017-2028)
Figure 66. South America Human Rabies Vaccines Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Human Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Human Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Human Rabies Vaccines Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Human Rabies Vaccines Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Human Rabies Vaccines Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Human Rabies Vaccines Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Human Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Human Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Human Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Human Rabies Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Human Rabies Vaccines in 2021
Figure 78. Manufacturing Process Analysis of Human Rabies Vaccines
Figure 79. Human Rabies Vaccines Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source